RU2490324C2 - ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ - Google Patents

ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ Download PDF

Info

Publication number
RU2490324C2
RU2490324C2 RU2010131018/10A RU2010131018A RU2490324C2 RU 2490324 C2 RU2490324 C2 RU 2490324C2 RU 2010131018/10 A RU2010131018/10 A RU 2010131018/10A RU 2010131018 A RU2010131018 A RU 2010131018A RU 2490324 C2 RU2490324 C2 RU 2490324C2
Authority
RU
Russia
Prior art keywords
yeast
scpro1
cells
scb1
dry
Prior art date
Application number
RU2010131018/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2010131018A (ru
Inventor
Жан-Люк СИМОН
Жорж ПИНЬЕД
Паскаль ВАНДЕКЕРКОВ
Даниель ПУЛЕН
Пьер Десремо
Арлетт ДАРФЕЙ-МИШО
Аделин СИВИНЬОН
Original Assignee
Лезаффр Э Компани
Юниверсите Д'Овернь Клермон 1
Юниверсите Дю Друа Э Де Ля Санте Лилль 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0801342A external-priority patent/FR2928652B1/fr
Application filed by Лезаффр Э Компани, Юниверсите Д'Овернь Клермон 1, Юниверсите Дю Друа Э Де Ля Санте Лилль 2 filed Critical Лезаффр Э Компани
Publication of RU2010131018A publication Critical patent/RU2010131018A/ru
Application granted granted Critical
Publication of RU2490324C2 publication Critical patent/RU2490324C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
RU2010131018/10A 2007-12-26 2008-12-12 ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ RU2490324C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0760377 2007-12-26
FR0760377 2007-12-26
FR0801342A FR2928652B1 (fr) 2008-03-12 2008-03-12 Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
FR0801342 2008-03-12
PCT/FR2008/001729 WO2009103884A2 (fr) 2007-12-26 2008-12-12 Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures

Publications (2)

Publication Number Publication Date
RU2010131018A RU2010131018A (ru) 2012-02-10
RU2490324C2 true RU2490324C2 (ru) 2013-08-20

Family

ID=40985983

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010131018/10A RU2490324C2 (ru) 2007-12-26 2008-12-12 ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ

Country Status (24)

Country Link
US (1) US8476058B2 (cg-RX-API-DMAC7.html)
EP (1) EP2227539B1 (cg-RX-API-DMAC7.html)
JP (1) JP5497661B2 (cg-RX-API-DMAC7.html)
KR (1) KR101654537B1 (cg-RX-API-DMAC7.html)
CN (1) CN101918536B (cg-RX-API-DMAC7.html)
AU (1) AU2008351156B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820068B8 (cg-RX-API-DMAC7.html)
CA (1) CA2709850C (cg-RX-API-DMAC7.html)
DK (1) DK2227539T3 (cg-RX-API-DMAC7.html)
ES (1) ES2649914T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171632T1 (cg-RX-API-DMAC7.html)
HU (1) HUE034628T2 (cg-RX-API-DMAC7.html)
IL (1) IL206110A (cg-RX-API-DMAC7.html)
LT (1) LT2227539T (cg-RX-API-DMAC7.html)
MX (1) MX2010007011A (cg-RX-API-DMAC7.html)
MY (1) MY159379A (cg-RX-API-DMAC7.html)
NO (1) NO2227539T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ586417A (cg-RX-API-DMAC7.html)
PL (1) PL2227539T3 (cg-RX-API-DMAC7.html)
RU (1) RU2490324C2 (cg-RX-API-DMAC7.html)
SI (1) SI2227539T1 (cg-RX-API-DMAC7.html)
TN (1) TN2010000239A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009103884A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003978B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2798521C1 (ru) * 2022-10-30 2023-06-23 Общество с ограниченной ответственностью "Микробные нутриенты иммунокорректоры" Синбиотическое средство на основе жизнеспособной биомассы штамма дрожжей Meyerozyma (Pichia) guilliermondii ВКПМ Y-4316

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균
FR2949043B1 (fr) * 2009-08-17 2013-05-17 Lesaffre & Cie Pate boulangere fermentee tolerante a l'appret
KR101933232B1 (ko) * 2011-03-04 2019-03-15 라이온 가부시키가이샤 성장 호르몬 분비 촉진제
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
WO2015061798A2 (en) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions and methods comprising yeast organisms and lipid extracts thereof
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101837160B1 (ko) 2016-07-20 2018-03-09 서울대학교산학협력단 신균주 bt-sjp kctc12726bp 및 이의 용도
WO2018052082A1 (ja) * 2016-09-14 2018-03-22 株式会社Ｔｅｓホールディングス Ｌｉｎ２８ａ活性化剤及びその使用
US11523625B2 (en) 2017-08-07 2022-12-13 Techmix, Llc Feed supplement bolus with active yeast
CN109536370A (zh) * 2018-12-10 2019-03-29 浙江华康药业股份有限公司 一种体外发酵糖醇益生功能评价装置及方法
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
FR3090318B1 (fr) 2018-12-19 2024-06-14 Lesaffre & Cie Souche Saccharomyces cerevisiae var boulardii en santé orale
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny
FR3096891B1 (fr) 2019-06-04 2022-05-13 Lesaffre & Cie Composition pour la prevention de la cystite simple et/ou recidivante
CN112273657A (zh) * 2019-07-22 2021-01-29 安琪酵母股份有限公司 用于预防或改善过敏性疾病的益生菌组合物、制法和应用
KR102275115B1 (ko) * 2019-10-16 2021-07-07 한국식품연구원 프로바이오틱 활성을 갖는 사카로마이세스 세레비지애 보울라디­０３ 신균주 및 이의 용도
FR3120789B1 (fr) 2021-03-16 2024-01-19 Lesaffre & Cie Inhibiteurs glycosidiques de levure
CA3223134A1 (en) 2021-06-30 2023-01-05 Carlos DE LECEA Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
CN118354680A (zh) * 2021-06-30 2024-07-16 英联马利(英国)有限公司 用于治疗胃肠障碍的生理学上可接受的酵母菌组合物
FR3134581B1 (fr) * 2022-04-15 2026-02-27 Lesaffre & Cie Levure Saccharomyces cerevisiae et son utilisation pour améliorer la santé intestinale des animaux de compagnie.
WO2025115611A1 (ja) * 2023-11-30 2025-06-05 株式会社日清製粉グループ本社 免疫調節剤
EP4732843A1 (en) 2024-10-22 2026-04-29 Lesaffre et Compagnie Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
US6783780B1 (en) * 1998-12-09 2004-08-31 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
WO2006021965A1 (en) * 2004-08-23 2006-03-02 Bharat Biotech International Limited Eukaryotic based synergistic formulation for gastro-intestinal disorders
US20060140973A1 (en) * 2004-12-23 2006-06-29 Bernard Hublot Method for treating weight loss in patients suffering from inflammatory bowel diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
FR2928652B1 (fr) 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783780B1 (en) * 1998-12-09 2004-08-31 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
WO2006021965A1 (en) * 2004-08-23 2006-03-02 Bharat Biotech International Limited Eukaryotic based synergistic formulation for gastro-intestinal disorders
US20060140973A1 (en) * 2004-12-23 2006-06-29 Bernard Hublot Method for treating weight loss in patients suffering from inflammatory bowel diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DALMASSO G. ET AL. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping Т cells in mesenteric limph nodes // Gastroenterology 2006, 131 pp.1812-1825. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2798521C1 (ru) * 2022-10-30 2023-06-23 Общество с ограниченной ответственностью "Микробные нутриенты иммунокорректоры" Синбиотическое средство на основе жизнеспособной биомассы штамма дрожжей Meyerozyma (Pichia) guilliermondii ВКПМ Y-4316

Also Published As

Publication number Publication date
LT2227539T (lt) 2017-11-27
US20100303778A1 (en) 2010-12-02
EP2227539B1 (fr) 2017-08-09
MY159379A (en) 2016-12-30
DK2227539T3 (da) 2017-11-13
US8476058B2 (en) 2013-07-02
RU2010131018A (ru) 2012-02-10
AU2008351156B2 (en) 2013-10-17
SI2227539T1 (en) 2018-03-30
WO2009103884A3 (fr) 2009-12-17
NO2227539T3 (cg-RX-API-DMAC7.html) 2018-01-06
ZA201003978B (en) 2012-02-29
AU2008351156A1 (en) 2009-08-27
IL206110A0 (en) 2010-11-30
BRPI0820068B1 (pt) 2020-03-17
WO2009103884A2 (fr) 2009-08-27
KR101654537B1 (ko) 2016-09-06
CA2709850C (fr) 2018-03-20
JP5497661B2 (ja) 2014-05-21
EP2227539A2 (fr) 2010-09-15
IL206110A (en) 2013-07-31
CA2709850A1 (fr) 2009-08-27
TN2010000239A1 (fr) 2011-11-11
JP2011509651A (ja) 2011-03-31
NZ586417A (en) 2012-07-27
HUE034628T2 (hu) 2018-02-28
HRP20171632T1 (hr) 2017-12-15
KR20110066118A (ko) 2011-06-16
PL2227539T3 (pl) 2018-01-31
BRPI0820068A2 (pt) 2015-09-01
BRPI0820068B8 (pt) 2021-07-27
CN101918536B (zh) 2013-07-03
MX2010007011A (es) 2010-10-13
CN101918536A (zh) 2010-12-15
ES2649914T3 (es) 2018-01-16

Similar Documents

Publication Publication Date Title
RU2490324C2 (ru) ДРОЖЖИ Saccharomyces cerevisiae, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ПРОБИОТИКА, И КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
CN114317353B (zh) 一种植物乳杆菌zjufyj7及其应用
CN103314099B (zh) 具有代谢综合症改善效果的乳酸菌
TWI463986B (zh) 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
CN107075455B (zh) 具有抗炎症及代谢疾病改善功效的植物乳杆菌hac01菌株及其用途
JP7492584B2 (ja) ビフィドバクテリウム・ラクティスｂｌ－９９の腸管炎症の抑制における新規な用途
US20080268006A1 (en) Probiotic Lactobacillus Strains for Improved Vaginal Health
MX2012009945A (es) Preparacion que contiene bacteria de acido lactico.
JP2020074751A (ja) ビフィドバクテリウム ラクティス ｇｋｋ２、それを含む組成物、およびアレルギー性喘息改善のためのその使用
CN117701477A (zh) 一株副干酪乳酪杆菌及其在改善肠道疾病中的应用
ES2553177T3 (es) Cepas de Lactobacillus plantarum como probióticos con efecto inmunomodulador especifico
CN110023486B (zh) 一种嗜酸乳杆菌及其培养方法和应用
CN117122620B (zh) Akkermansia muciniphila在制备预防、治疗和/或辅助治疗关节炎的产品中的应用
CN116004472A (zh) 一株缓解肥胖的丁酸梭菌及其应用
FR2928652A1 (fr) Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
TW201609120A (zh) 含乳酸菌之腸道屏障功能促進劑
CN114107083B (zh) 新颖乳酸菌及其用于治疗或预防肝脏损伤相关疾病的用途
RU2803259C1 (ru) Метабиотическая композиция на основе метаболитов Bacillus subtilis
JP2026055457A (ja) ラクチプランチバチルス属乳酸菌を含む組成物
RU2708146C2 (ru) Средство для улучшения состояния пищеварения
JP2006257040A (ja) アレルゲン特異的ＩｇＥ抗体産生抑制剤、及びアレルゲン特異的ＩｇＥ抗体産生抑制のために用いられる飲食品
De Preter et al. T2036 The Prebiotic Oligofructose-Enriched Inulin Affects the Faecal Metabolite Fingerprint: An In Vitro Analysis
Family Dedicated To My Lovely Family and Guide
McClemens et al. T2037 Treatment With Probiotic Bacteria During Enteric Parasite Infection Upregulates Goblet Cell Hyperplasia and Promotes Host Defense
Kabeerdoss et al. T2038 Diversity and Numbers of Clostridium leptum Group Bacteria in Indian Patients With Ulcerative Colitis and Crohn's Disease